• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
Class
Fibrinolytic
Mechanism of Action
The enzyme binds to the fibrin bound plasminogen at the clot site, converting plasminogen to plasmin. Plasmin digests the fibrin strands of the clot, restoring perfusion.
Indications
Acute MI, STEMI, massive pulmonary emboli, acute ischemic cerebrovascular accident
Contraindications
Active internal bleeding, recent surgery (within 2-3 weeks), previous cerebrovascular accident or seizure at onset, prolonged CPR,intracranial or intraspinal surgery (w/ in 3 months), intracranial neoplasm, arteriovenous malformation, or aneurysm, recent significant trauma especially head trauma. Uncontrolled hypertension (systolic >185, diastolic >110)
Adverse reactions/ side effect
Intracranial bleeding, headache, reperfusion, dysrhythmias, chest pain, hypotension, GI bleeding, nausea, vomiting, abd pain
Drug Interactions
Acetylsalicylic acid (aspirin) may increase risk of bleeding hemorrhage. Heparin and other anti-coagulants may increase risk or hemorrhage
How Supplied
50 and 100 mg powders (requires reconstitution with sterile water to a concentration of 1 mg/mL)
Dosage and admin
Adult: 15 mg IV bolus over 2 min, then .75 mg/kg over 30 min (not to exceed 50 mg); then .50 mg/kg over 60 min, maximum total dose of 100 mg. For acute ischemic stroke, .9 mg 1 kg infused over 60 min; administer 10% of total dose in 1 min and rest over next 60 min.

Pedi: safety not established
Duration of Action
Onet: Clot lysis most often within 60-90 minutes
Peak effect:Variable
Duration: 30 minutes with 80% cleared within 10 min
Special Consideration
Pregnancy safety. Cat. C. Closely monitor V/S. Observe for bleeding. Do not administer IM injections to pt receiving tissue plasminogen activator. Only administer with an infusion pump. Due to severe spontaneous bleeding risk, invasive procedures (eg. IV starts, injections, NG tube, nasotracheal intubation) should be avoided.